Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $10.3750 (-0.14%) ($10.3750 - $10.3750) on Fri. Feb. 11, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.67% (three month average) | RSI | 41 | Latest Price | $10.3750(-0.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 0.3% a day on average for past five trading days. | Weekly Trend | TGTX declines -7.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(77%) ARKG(72%) IBB(70%) ARKK(67%) IBUY(62%) | Factors Impacting TGTX price | TGTX will decline at least -4.335% in a week (0% probabilities). VIXM(-49%) VXX(-40%) UUP(-24%) TBT(-11%) USO(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.335% (StdDev 8.67%) | Hourly BBV | -2.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-21.22(-304.53%) | Resistance Level | $11.89 | 5 Day Moving Average | $10.47(-0.91%) | 10 Day Moving Average | $10.67(-2.76%) | 20 Day Moving Average | $11.89(-12.74%) | To recent high | -68.7% | To recent low | 22.4% | Market Cap | $1.314b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |